Rhythm Pharmaceuticals, Inc. (RYTM)

112.28 -0.07 (-0.06%) USD  |  NASDAQ  |  Dec 24, 12:59
More

Rhythm Pharmaceuticals SG&A Expense (TTM): 175.59M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for RYTM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Eli Lilly & Co. 10.39B
Gilead Sciences, Inc. 5.886B
Johnson & Johnson 23.38B
Terns Pharmaceuticals, Inc. 31.48M
ACADIA Pharmaceuticals, Inc. 523.36M